drugset / Trial / NCT01017198

Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors

NCT01017198

Phase 1 Completed 20 enrolled Biogen
RandomizedCrossoverOpen-labelTreatment

Summary

This study is designed to assess the effect of food and antacid use on the pharmacokinetic properties of BIIB021.

Timeline

Start
2009-11
Primary completion
2010-08
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject BIIB021 Small molecule 100 mg
Subject BIIB021 Small molecule 450 mg
Background Ranitidine Unknown 150 mg

Indications